Each sequencing cycle links nucleotide incorporation to a detectable signal, and repeated cycles build the sequence information for individual DNA or RNA-derived fragments. Because many fragments are processed in parallel, the instrument generates a large collection of sequence reads in one run. These reads provide the raw material for identifying genetic features relevant to infection and immunity.
These configurations describe how fragments are presented for detection during sequencing. Fragments may be attached to a flow cell or another surface and amplified, or they may be analyzed as single molecules. The selected arrangement determines how the instrument captures signals from the material, while the resulting reads support downstream assembly or alignment.
Assembly combines sequence information from fragments to reconstruct broader genetic regions, whereas alignment compares reads with relevant reference sequences or genomic targets. Together, these computational approaches transform instrument output into interpretable findings, such as pathogen identification, mutation detection, antimicrobial-resistance genes, or patterns within immune-receptor repertoires.
The workflow begins with nucleic acid extraction, followed by library preparation that converts the recovered material into sequencing-ready fragments. Those fragments are then attached to a flow cell or another detection surface, or prepared for single-molecule analysis, depending on the sequencing configuration. This sequence of steps connects biological samples with instrument-readable signals.
It is useful when researchers need to examine genetic material across complex infection-related samples or track changes across groups and time. Supported applications include metagenomics, outbreak surveillance, pathogen identification, mutation analysis, and detection of antimicrobial-resistance genes. These uses allow studies to characterize infectious agents and investigate their genetic variation.
In immunology, the resulting sequence data can characterize immune-receptor repertoires and contribute to studies of host-pathogen interactions. The same platform can also support vaccine research by revealing genetic information associated with infectious organisms and host responses. This combination connects sequence-level measurements with questions about immune diversity and infection biology.